About Us

About Liberi Group

Liberi Group is a global life science consultancy firm, with a primary focus on life sciences partnering and valuations for biotech companies. We specialize in creating financial, strategic, and scientific collaborations for our clients in the life sciences sector.

Our expertise in value services ensures that our clients maximize the value of their assets, partnerships, and business strategies. While our primary focus is on biotech, we also support pharmaceutical companies, particularly in divestment activities.

Our global network
1100+
Pharma
1100+
Investors
1100+
Biotech

At Liberi Group, we prioritize personal connections and tailored approaches to drive successful partnerships. Our expansive global network enables us to connect with investors, strategics, and pharmaceutical companies. We actively attend all major life sciences conferences and frequently travel across Europe, Asia, and the USA to engage with our network, clients, and industry professionals.

Our current biotech client base is geographically diverse:

  • 30% from the USA
  • 30% from Europe
  • 40% from and towards Asia (a rapidly growing segment)

We bridge business development opportunities across the EU, USA, and Asia, forming a global triangle of innovation and growth.

"We have been working with the team for almost 10 years now and thanks to a real partnership relationship that has been established throughout these years, our company is now on the path to scientific and commercial success. Thanks for all to Liberi Group."
Cédric Bories, President AGV Discovery

Follow us here!

Our Expertise

We work closely with decision-makers in the biotech and life sciences industry, offering partnering services and data-driven value services that help shape critical business decisions. Our detailed asset valuation assessments and strategic insights empower companies to negotiate better deals, secure investments, and optimize their business models.

We are therapeutically agnostic and work with companies specializing in:

Therapeutics
Diagnostics
Platforms
Animal Health

Over the years, we have successfully facilitated strategic partnerships and valuation assessments for biotech and pharmaceutical companies. We support our clients in multiple business development models, including:


Out-licensing
Search and Evaluation for in-licensing (primarily for pharma)
Co-Development
Fundrasing from Seed to Post-IPO
Divesting assets
Mergers & Acquisitions (M&A)
Value Services for assets and pipelines
Learn more about our services

Why Choose Liberi Group?

Our personalized, hands-on approach makes us stand out as a leading global consultancy in life sciences partnering and valuation. We combine financial expertise, deep industry knowledge, and a strong network to deliver actionable insights that drive success.

Let’s connect and explore new growth opportunities together!

Connect
Image
Antibodies
Autoimmune
Cardiovascular
Cell Therapy
CNS
Cosmetic
Dermatology
Endocrinology
Gastroenterology
Gene therapy
Genetic Disorders
Hematology
Neurology
Oncology
Opthalmology
Orthopaedics
Repurposed
ENT
Pain
Pediatric Diseases
Platform technologies
Proctology
Psychiatry
Pulmonology
Rare diseases
Rheumatology
Rhinology
Urology
Vascular system
Viral vectors
Women's health
505(b)2

Meet the team

The Team

Meet us in person

Meet us in person at one of these upcoming conferences or business visits.
Want to schedule a meeting? Get in touch!

Past Events

JPM/Biotech Showcase 2025

13 January 2025
 - 16 January 2025
Liberi Group attended JPM & Biotech Showcase in San Francisco, US with 3 delegates.
JPM Life Science Conference 2025

Bio Europe Fall 2024

4 November 2024
 - 6 November 2024
Liberi Group attended Bio Europe Fall in Stockholm, Sweden with 3 representatives
Liberi Group team attending Bio Europe Fall

CPHI Milan 2024

8 October 2024
 - 10 October 2024
Liberi Group attended CPHI in Milan with 2 delegates.
Liberi Group attending CPHI
View more